Molecular action of methotrexate in inflammatory diseases
-
* Corresponding author: Bruce N Cronstein cronsb01@med.nyu.edu
Arthritis Res 2002, 4:266-273 doi:10.1186/ar419
Accesses
- Last 30 days: 219 accesses
- Last 365 days: 1604 accesses
- All time: 15938 accesses
Cited by
BioMed Central: 5 citations
|
Research article
Benoit Le Goff, Elise Soltner, Céline Charrier, Yves Maugars, Françoise Rédini, Dominique Heymann, Jean-Marie Berthelot Arthritis Research & Therapy 2009, 11:R185 (10 December 2009) |
|
Review
Psoriatic arthritis: from pathogenesis to therapy Oliver FitzGerald, Robert Winchester Arthritis Research & Therapy 2009, 11:214 (12 February 2009) |
|
Research article
Avivit Ochaion, Sara Bar-Yehuda, Shira Cohn, Luis Del Valle, Georginia Perez-Liz, Lea Madi, Faina Barer, Motti Farbstein, Sari Fishman-Furman, Tatiana Reitblat, Alexander Reitblat, Howard Amital, Yair Levi, Yair Molad, Reuven Mader, Moshe Tishler, Pnina Langevitz, Alexander Zabutti, Pnina Fishman Arthritis Research & Therapy 2006, 8:R169 (13 November 2006) Methotrexate potentiates the effects of the new anti-inflammatory CF101 in vivo, which supports the combined use of these drugs to treat rheumatoid arthritis.
|
|
Research article
Rille Pullerits, Maria Bokarewa, Leif Dahlberg, Andrej Tarkowski Arthritis Research & Therapy 2005, 7:R817-R824 (25 April 2005) |
|
Research article
Eleni Douni, Petros P Sfikakis, Sylva Haralambous, Peter Fernandes, George Kollias Arthritis Res Ther 2004, 6:R65-R72 (7 November 2003) |